Browse > Article
http://dx.doi.org/10.22246/jikm.2018.39.6.1206

Clinical Effectiveness of Acupuncture in the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review  

Hyun, Joon (Dept. of Korean Medicine, School of Korean Medicine, Pusan National University)
Lee, Joo-bok (Dept. of Korean Medicine, School of Korean Medicine, Pusan National University)
Kim, So-yeon (Dept. of Korean Medicine, School of Korean Medicine, Pusan National University)
Han, Chang-woo (Dept. of Korean Medicine, School of Korean Medicine, Pusan National University)
Publication Information
The Journal of Internal Korean Medicine / v.39, no.6, 2018 , pp. 1206-1224 More about this Journal
Abstract
Purpose: This systematic review was planned and performed in order to determine the clinical effectiveness of acupuncture for non-alcoholic fatty liver disease (NAFLD). Methods: We searched related randomized controlled trials in several medical online databases, including China National Knowledge Infrastructure (CNKI), Excerpta Medica dataBASE (EMBASE), Public/Publisher MEDLINE (PubMed), Cochrane Central Register of Controlled Trials (CENTRAL), National Digital Science Library (NDSL), and Research Information Sharing Service (RISS). NAFLD related outcomes were extracted from the included trials and meta-analyzed. Results: From the 8 included trials, the values of the following examinations were extracted: liver ultrasonography, liver CT, body fat CT, aspartate transaminase (AST), alanine transaminase (ALT), gamma-glutamyltransferase (GGT), total cholesterol (TC), triglyceride (TG), low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, fasting blood sugar (FBS), hosmeostatic model assessment for insulin resistance (HOMA-IR), weight, body mass index (BMI), waist hip ratio (WHR), obesity degree, body fat mass, body fat rate, leptin, malondialdehyde (MDA), and super oxide dismutase (SOD). In the 4 outcomes, cure rate in liver ultrasonography (RR=1.56; 95%CI=1.05~2.31; P=0.03), cure rate in liver CT (RR=2.23; 95%CI=1.33~3.72; P=0.002), TC (MD=-0.78; 95%CI=-1.41~-0.15; P=0.02), and TG (MD=-2.05; 95%CI=-3.88~-0.21; P=0.03), acupuncture was more effective than the control intervention. Conclusions: In this meta-analysis, acupuncture relieved hepatic steatosis, and reduced TC, and TG in NAFLD patients. more well-planned studies are still needed due to the heterogeneity and the considerable methodological flaws in the analyzed trials.
Keywords
non-alcoholic fatty liver disease; acupuncture; systematic review;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhang QL. Observation and nursing of non alcohol fatty liver disease treated with acupuncture therapy. Chinese community doctors 2015;31(32):153-5.
2 Huang Z, Song S, Tan K, Chu J, Zhu X, Zeng Y. Non-alcoholic fatty liver disease of liver stagnation and spleen deficiency pattern treated with acupoint embedding therapy: a randomized controlled trial. Zhongguo Zhen Jiu 2016;36(2):119-23.
3 Lee CH, Lim BS, Choi AR, Kim KS, Kwak MA, Kim SM. The effects of electroacupuncture for treatment of patients with non-alcoholic fatty liver disease: prospective randomized controlled study. J Korean Med Obes Res 2015;15(1):1-8.   DOI
4 Wikipedia_Homeostatic model assessment. Available from: https://en.wikipedia.org (Accessed on November 20, 2018.)
5 Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 2018;67(1):328-57.   DOI
6 National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143-421.   DOI
7 Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112(17):2735-52.   DOI
8 Sheth SG, Chopra S. Epidemiology, clinical features, and diagnosis of nonalcoholic fatty liver disease in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. Available from www.uptodate.com (Accessed on November 20, 2018.)
9 Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 2011;9(6):524-30.e1.   DOI
10 Park SH, Kim BI, Yoo TW, Kim JW, Cho YK, Sung IK, et al. Nonalcoholic fatty liver disease and abnormal liver function test in the health screen examinees: the relationship with insulin resistence. Korean J Gastroenterol 2003;41(5):366-73.
11 Jeong EH, Jun DW, Cho YK, Choe YG, Ryu S, Lee SM, et al. Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea. Clin Mol Hepatol 2013;19(3):266-72.   DOI
12 Chopra S, Lai M. Management of nonalcoholic fatty liver disease in adults. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. Available from www.uptodate.com (Accessed on November 20, 2018.)
13 The Spleen and Stomach disease branch of China association of Chinese medicine. Expert consensus on TCM diagnosis and treatment of NAFLD. Beijing Journal of Traditional Chinese Medicine2011;30(2):83-6.
14 NIH Consensus Development Panel on Acupuncture. NIH consensus conference. Acupuncture. JAMA 1998;280(17):1518-24.   DOI
15 Higgins JPT, Green S, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. 1st edition. Chichester, England; Hoboken, NJ: Wiley-Blackwell; 2008, p. 187-242.
16 Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107(4):1103-9.   DOI
17 Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011;54(3):1082-90.   DOI
18 Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004;14(5):635-7.   DOI
19 Cho CS, Curran S, Schwartz LH, Kooby DA, Klimstra DS, Shia J, et al. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 2008;206(3):480-8.   DOI
20 Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol1999;94(4):1018-22.   DOI
21 Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci1980;12(1):1-58.   DOI
22 Lum G, Gambino SR. Serum gamma-glutamyl transpeptidase activity as an indicator of disease of liver, pancreas, or bone. Clin chem 1972;18(4):358-62.   DOI
23 Lim JS, Lee DH, Park JY, Jin SH, Jacobs DR Jr. A strong interaction between serum gamma-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the Third National Health and Nutrition Examination Survey. Clin Chem 2007;53(6):1092-8.   DOI
24 Lin JX, Huang YF, Yin MY, Xu MY, Yin L, Lu LP, et al. Sixty cases of non-alcoholic fatty liver treated with TCM community comprehensive intervention. Henan traditional chinese medicine 2015;35(8):1830-2.
25 Huang Z, Song SL, Tan KP, Chu JM, Chu XY, Zeng YH, et al. Observation on clinical effects of acupoint thread-embedding method for non-alcoholic fatty liver disease. J Acupunct Tuina Sci2016;14(03):186-91.   DOI
26 Assy N. Treatment of non alcoholic fatty liver disease with lifestyle modification and acupuncture. 2013. Available from Https://clinicaltrialsgov/show/nct02006329. (Accessed on March 20, 2018.)
27 Wang N, Tan QW. Electroacupuncture at Jiaji (extra points) for 30 cases of nonalcoholic fatty liver disease. Zhongguo Zhen Jiu 2013;33(8):717-8.
28 Xia SY. Therapeutic observation of acupuncture plus Chinese herbal medicine for nonalcoholic fatty liver disease. Shanghai J Acu-mox 2015;34(5):428-30.
29 Jin JJ, Xu YL, Zheng Y. Effects of acupoint-injection of Kaixilai on TG, TC, MDA, SOD, AST and ALT in the patient of non-alcoholic fatty liver. Zhongguo Zhen Jiu 2006;26(2):100-2.
30 Meng SX. Observation on therapeutic effect of acupuncture for treatment of patients with nonalcoholic steatohepatitis. Zhongguo Zhen Jiu 2009;29(8):616-8.
31 Liu XD, Wang M, Li YZ. Clinical observation on acupoint catgut embedding for treatment of non-alcoholic steatohepatitis. Zhongguo Zhen Jiu 2010;30(8):637-41.
32 Zhou XL, Xie S, Xiao WS, Yin XL. Effect of acupoint catgut embedding and Qiangganxiaozhi decoction on serum leptin and insulin resistance of nonalcoholic fatty liver disease. JETCM 2010;19(11):1845-7.
33 Pan H, Guo J, Su Z. Advances in understanding the interrelations between leptin resistance and obesity. Physiol Behav 2014;130:157-69.   DOI
34 Rio DD, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005;15(4):316-28.   DOI
35 Wikipedia_Superoxide dismutase. Available from: https://en.wikipedia.org (Accessed on November 20, 2018.)
36 Brennan AM, Mantzoros CS. Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat Clin Pract Endocrinol Metab 2006;2(6):318-27.   DOI
37 Zhou X, Xie S, Hou Q. Effects of catgut implantation and Qianggan Xiaozhi Yin on skin temperature of acupuncture point of foot three Yin meridians in patiens with nonalcoholic steatohepatitis. Modern journal of integrated Chinese traditional and western medicine2011;20(31):3909-11.
38 Hayyan M, Hashim MA, AlNashef IM. Superoxide ion: generation and chemical implications. Chem Rev 2016;116(5):3029-85.   DOI